Crossmark

A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug Act

Crossref DOI link: https://doi.org/10.1186/s13023-023-02790-7

Published Online: 2023-06-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fermaglich, Lewis J. http://orcid.org/0000-0001-7151-1615
Miller, Kathleen L.
License Information

Text and Data Mining valid from 2023-06-23

Version of Record valid from 2023-06-23
More Information

Article History

Received: 14 April 2023

Accepted: 18 June 2023

First Online: 23 June 2023

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below